Evidence map›Paper›PMID 28348479›Full record

ReviewWorld journal of gastroenterology2017

Non-alcoholic fatty liver disease connections with fat-free tissues: A focus on bone and skeletal muscle.

Eleonora Poggiogalle, Lorenzo Maria Donini, Andrea Lenzi, Claudio Chiesa, Lucia Pacifico

2 registry-linked trialsOpen access · hybridAbstract readReview
In one paragraph

Review in World journal of gastroenterology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04850547 unknown statusnot on this mapstarted 2021, after this paper: background citation

Vitamin D Status and Bone Turnover Markers in Patients With Non Alcoholic Fatty Liver Disease

TypeobservationalSponsorSohag UniversityRan2021 to 2022Enrolled80ConditionsNon-Alcoholic Fatty Liver Disease, Osteoporosis
NCT06038253 not yet recruitingnot on this mapstarted 2023, after this paper: background citation

Relation Between Non- Alcoholic Fatty Liver Disease and Bone Mineral Density in Egyptian Adults

TypeobservationalSponsorAssiut UniversityRan2023 to 2026Enrolled100ConditionsNAFLD, OsteoporosisArmsFibroscan
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 47 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. [Metabolic-associated fatty liver disease (MAFLD): a multisystemic disease beyond the liver].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Eleonora PoggiogalleEleonora Poggiogalle, Lorenzo Maria Donini, Andrea Lenzi, Department of Experimental Medicine- Medical Pathophysiology, Food Science and Endocrinology Section, Sapienza University of Rome, 00185 Rome, Italy.
Lorenzo Maria DoniniEleonora Poggiogalle, Lorenzo Maria Donini, Andrea Lenzi, Department of Experimental Medicine- Medical Pathophysiology, Food Science and Endocrinology Section, Sapienza University of Rome, 00185 Rome, Italy.
Andrea LenziEleonora Poggiogalle, Lorenzo Maria Donini, Andrea Lenzi, Department of Experimental Medicine- Medical Pathophysiology, Food Science and Endocrinology Section, Sapienza University of Rome, 00185 Rome, Italy.
Claudio ChiesaEleonora Poggiogalle, Lorenzo Maria Donini, Andrea Lenzi, Department of Experimental Medicine- Medical Pathophysiology, Food Science and Endocrinology Section, Sapienza University of Rome, 00185 Rome, Italy.
Lucia PacificoEleonora Poggiogalle, Lorenzo Maria Donini, Andrea Lenzi, Department of Experimental Medicine- Medical Pathophysiology, Food Science and Endocrinology Section, Sapienza University of Rome, 00185 Rome, Italy.
Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences · RUPoliclinico Umberto I · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The estimates of global incidence and prevalence of non-alcoholic fatty liver disease (NAFLD) are worrisome, due to the parallel burden of obesity and its metabolic complications. Indeed, excess adiposity and insulin resistance represent two of the major risk factors for NAFLD; interestingly, in the last years a growing body of evidence tended to support a novel mechanistic perspective, in which the liver is at the center of a complex interplay involving organs and systems, other than adipose tissue and glucose homeostasis. Bone and the skeletal muscle are fat- free tissues which appeared to be independently associated with NAFLD in several cross-sectional studies. The deterioration of bone mineral density and lean body mass, leading to osteoporosis and sarcopenia, respectively, are age-related processes. The prevalence of NAFLD also increases with age. Beyond physiological aging, the three conditions share some common underlying mechanisms, and their elucidations could be of paramount importance to design more effective treatment strategies for the management of NAFLD. In this review, we provide an overview on epidemiological data as well as on potential contributors to the connections of NAFLD with bone and skeletal muscle.

Indexed as

Absorptiometry, PhotonAge FactorsBone and BonesBone DensityHuman Growth HormoneHumansIncidenceInsulin-Like Growth Factor IInsulin ResistanceMuscle, SkeletalNon-alcoholic Fatty Liver DiseaseObesityOsteocalcinOsteoporosisPrevalenceRisk FactorsHuman Growth HormoneIGF1 protein, humanInsulin-Like Growth Factor IOsteocalcinBoneNon-alcoholic fatty liver diseaseOsteoporosisSarcopeniaSkeletal muscle

Identifiers

PMID28348479
PMCPMC5352914
OpenAlexW2596807131

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.